The Cann Global Ltd (ASX: CGB) share price is zooming higher on Tuesday.
In morning trade the cannabis company’s shares are up 13% to 1.7 cents.
Why is the Cann Global share price on a high today?
This morning Cann Global announced an agreement to secure the exclusive rights to the intellectual property of the unique medicinal cannabis formulations that have been used by Olivia Newton John in her recent health challenge.
According to the release, these formulations are known as XO 27 XP, and ONJ 18 XP and ONJ XO. They are intended to be distributed to the global marketplace under Cann Global’s label.
The release explains that these cannabis formulations have been uniquely developed, formulated, and researched over the past six years by Newton John’s husband and world-renowned, plant-derived medical formulations expert John Easterling.
Mr Easterling is a non-executive director of Cann Global.
The existence of these formulations has recently been widely publicised in the media by Newton John. She attributes, in conjunction with her conventional treatments, much of her recent positive developments in the restoration of her health to these formulations.
Newton John reported improvements in three main areas: 1) Pain relief 2) Increased mobility 3) Increased healthy blood count numbers.
Olivia Newton John said: “John’s unique cannabis formulas have been a huge help to me with sleep, stress, mood, and of course pain. I was able to wean myself completely off morphine and all pain meds using cannabis which is something I think everyone should know is possible.”
Cann Global intends to produce these formulations in Australia and make it available to patients as soon as possible through the Special Access Scheme, Medical Cannabis program. It will also explore its export potential to provide to patients globally.
The company also intends to actively support Olivia Newton John’s wish for clinical trials using these formulas to be conducted with cancer patients.
The post This ASX cannabis share is zooming higher on Olivia Newton John formulations news appeared first on Motley Fool Australia.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019